# Topical Betamethasone and Clobetasol in Orabase in Oral Lichen Planus

> **NCT03026478** · PHASE2 · UNKNOWN · sponsor: **Garlapati Komali** · enrollment: 30 (estimated)

## Conditions studied

- Oral Lichen Planus

## Interventions

- **DRUG:** Betamethasone Dipropionate
- **DRUG:** Clobetasol Propionate

## Key facts

- **NCT ID:** NCT03026478
- **Lead sponsor:** Garlapati Komali
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-05-06
- **Primary completion:** 2018-03
- **Final completion:** 2018-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2018-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03026478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03026478, "Topical Betamethasone and Clobetasol in Orabase in Oral Lichen Planus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03026478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*